Literature DB >> 30454767

Development of New Analgesics: An Answer to Opioid Epidemic.

Tony L Yaksh1, Matthew A Hunt2, Gilson G Dos Santos2.   

Abstract

Management of pain is a fundamental imperative in medicine. Current analgesics suffer from limitations related to efficacy and adverse events of which abuse potential has assumed an important role. Here we highlight the factors that drive the development of novel analgesics and the advances made in the field.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  analgesics; dependence; drug abuse; tolerance

Mesh:

Substances:

Year:  2018        PMID: 30454767     DOI: 10.1016/j.tips.2018.10.003

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  4 in total

1.  A new hypertonic saline assay for analgesic screening in mice: effects of animal strain, sex, and diurnal phase.

Authors:  Yahya I Asiri; Desmond H Fung; Timothy Fung; Alasdair M Barr; Ernest Puil; Stephan K W Schwarz; Bernard A MacLeod
Journal:  Can J Anaesth       Date:  2021-02-18       Impact factor: 5.063

2.  Soluble epoxide hydrolase inhibitor mediated analgesia lacks tolerance in rat models.

Authors:  Karen M Wagner; Jogen Atone; Bruce D Hammock
Journal:  Brain Res       Date:  2019-11-29       Impact factor: 3.252

Review 3.  Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis.

Authors:  Lauriane Delay; Gilson Gonçalves Dos Santos; Elayne Vieira Dias; Tony L Yaksh; Maripat Corr
Journal:  Rheum Dis Clin North Am       Date:  2021-02-26       Impact factor: 2.670

Review 4.  Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions.

Authors:  Ming Tatt Lee; Ken Mackie; Lih-Chu Chiou
Journal:  Br J Pharmacol       Date:  2021-12-07       Impact factor: 9.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.